Our Team
Audun Kvalvaag, Founder and CEO
Audun Kvalvaag did his PhD in Molecular Biology at the University of Oslo and Harvard Medical School. He then received a Marie-Curie Mobility Grant and moved to Oxford to do a PostDoc in Molecular Immunology. He is currently working as a SPARK Norway Project Manager at the Institute for Cancer Research, Oslo University Hospital. Through his research stays abroad, he realized that there is a lack of networking tools for scientists based on ongoing research projects and he has founded POSTR to remedy this.
Astrid Hilde Myrset, Co-Founder and Chairman of the Board.
Astrid has a PhD in biochemistry and started working in the life science industry as a researcher at Nycomed Imaging in 1994. After working in various roles, including knowledge manager and innovation manager in the Nycomed/Amersham/GE Healthcare system for 14 years, she started as CEO of a Norwegian start-up company in 2008. Since then, she has held management positions in several small companies, including as preclinical and clinical director and CEO and she is currently the CEO of the Norwegian Life Science company SurViva AS. She is passionate about sharing her knowledge and experiences to facilitate further development of the Norwegian Life Science industry.
Audun Kvalvaag, Founder and CEO
Audun Kvalvaag did his PhD in Molecular Biology at the University of Oslo and Harvard Medical School. He then received a Marie-Curie Mobility Grant and moved to Oxford to do a PostDoc in Molecular Immunology. He is currently working as a SPARK Norway Project Manager at the Institute for Cancer Research, Oslo University Hospital. Through his research stays abroad, he realized that there is a lack of networking tools for scientists based on ongoing research projects and he has founded POSTR to remedy this.
Astrid Hilde Myrset, Co-Founder and Chairman of the Board.
Astrid has a PhD in biochemistry and started working in the life science industry as a researcher at Nycomed Imaging in 1994. After working in various roles, including knowledge manager and innovation manager in the Nycomed/Amersham/GE Healthcare system for 14 years, she started as CEO of a Norwegian start-up company in 2008. Since then, she has held management positions in several small companies, including as preclinical and clinical director and CEO and she is currently the CEO of the Norwegian Life Science company SurViva AS. She is passionate about sharing her knowledge and experiences to facilitate further development of the Norwegian Life Science industry.